Biopharmaceutical R&D increasingly relies on digitization and automation, but legacy, fragmented informatics systems slow innovation. To support modern research needs, IT must adopt unified, configurable, and AI‑powered platforms that align with biopharma 4.0 principles. This new era combines Industry 4.0 technologies—automation, advanced analytics, and artificial intelligence—to streamline lab operations, eliminate bottlenecks, and accelerate drug discovery. By integrating data, enhancing workflows, and enabling adaptive digital processes, agile IT becomes essential for managing complex science and driving faster, more efficient breakthroughs.

Join for free to read